{"schema_version":"secwatch.filing_event.v1","accession":"0001127537-21-000033","form_type":"8-K","ticker":"LUNG","cik":"0001127537","company_name":"Pulmonx Corp","filed_at":"2021-08-02T23:59:59+00:00","discovered_at":"2026-05-14T18:04:17.227286+00:00","generated_at":"2026-06-29T23:47:18.282355+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Pulmonx appoints Alissa Hsu Lynch and Tiffany Sullivan as Class I directors","bullets":["Appointments effective July 29, 2021; directors serve until 2024 annual meeting.","Lynch joins Audit Committee; Sullivan joins Nominating and Corporate Governance Committee.","Each receives $40k annual cash fee, initial RSU grant of $180k vesting over 3 years, plus annual equity grants.","Each enters standard indemnification agreement with Pulmonx."],"urls":{"canonical":"https://secwatch.observer/filing/0001127537-21-000033","json":"https://secwatch.observer/filing/0001127537-21-000033.json","markdown":"https://secwatch.observer/filing/0001127537-21-000033.md","text":"https://secwatch.observer/filing/0001127537-21-000033.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1127537/000112753721000033/0001127537-21-000033-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1127537/000112753721000033/lung-20210729.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T23:47:18.282355+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ab1ad49288","claim":"Alissa Hsu Lynch was appointed as Class I Director at Pulmonx Corp.","evidence_excerpt":"Effective as of July 29, 2021, the Company’s Board of Directors (the “Board”) appointed Ms. Alissa Hsu Lynch and Ms. Tiffany Sullivan and to serve as Class I directors of the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1127537/000112753721000033/0001127537-21-000033-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class I Director"}],"fact_type":"executive_change"},{"claim_id":"ae21807da7","claim":"Tiffany Sullivan was appointed as Class I Director at Pulmonx Corp.","evidence_excerpt":"Effective as of July 29, 2021, the Company’s Board of Directors (the “Board”) appointed Ms. Alissa Hsu Lynch and Ms. Tiffany Sullivan and to serve as Class I directors of the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1127537/000112753721000033/0001127537-21-000033-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class I Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}